CBIH Unveils the Future of Wellness with Revolutionary Anti-Aging Chip our Research and Development team is redefining the possibilities of cannabinoid-based biotechnologies and at the heart of these innovations lies the Rejuv

CBIH Charts Path to Future Leadership in Cannabis Medicine A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...

Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation CBIH a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 billion dollar valuation.

CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward “Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer